Jianerkang Medical Co.,Ltd. (SHA:603205)
27.93
-0.27 (-0.96%)
At close: Feb 26, 2026
Jianerkang Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 701.04 | 721.81 | 226.24 | 178.25 | 97.8 | 94.69 |
Cash & Short-Term Investments | 736.23 | 721.81 | 226.24 | 178.25 | 97.8 | 94.69 |
Cash Growth | 138.08% | 219.05% | 26.92% | 82.27% | 3.28% | -30.22% |
Accounts Receivable | 222.67 | 212.32 | 235.5 | 189.16 | 138.75 | 127.94 |
Other Receivables | 9.87 | 14.4 | 9.04 | 4.43 | 6.96 | 12.36 |
Receivables | 232.54 | 226.72 | 244.54 | 193.59 | 145.71 | 140.3 |
Inventory | 171.11 | 176.3 | 158.41 | 170.44 | 158.62 | 170.69 |
Prepaid Expenses | - | - | 0.52 | 9.01 | 0.09 | 1.41 |
Other Current Assets | 12.78 | 10.32 | 11.07 | 20.71 | 8.39 | 4.88 |
Total Current Assets | 1,153 | 1,135 | 640.78 | 572.01 | 410.6 | 411.98 |
Property, Plant & Equipment | 399.19 | 365.42 | 383.67 | 356.1 | 326.67 | 305.16 |
Other Intangible Assets | 57.32 | 58.41 | 59.92 | 61.39 | 63.19 | 65.03 |
Long-Term Deferred Tax Assets | 25.28 | 23.02 | 23.12 | 25.96 | 24.37 | 22.42 |
Long-Term Deferred Charges | 10.29 | 6.6 | 3.02 | 2.09 | 2.07 | 1.38 |
Other Long-Term Assets | 3.6 | 1.97 | 3.06 | 10.93 | 13.52 | 17.29 |
Total Assets | 1,648 | 1,591 | 1,114 | 1,028 | 840.43 | 823.27 |
Accounts Payable | 106.1 | 87.33 | 103.14 | 95.25 | 73.14 | 144.92 |
Accrued Expenses | 15.84 | 27.74 | 34.07 | 42.3 | 31.45 | 29.17 |
Short-Term Debt | - | - | - | 30.04 | 50.05 | 69.55 |
Current Income Taxes Payable | 7.15 | 3.44 | 7.78 | 4.77 | 1.43 | 24.24 |
Current Unearned Revenue | 4.71 | 6.48 | 4.32 | 8.85 | 4.59 | 30.02 |
Other Current Liabilities | 1.15 | 9.74 | 16.47 | 21.98 | 14.76 | 0.56 |
Total Current Liabilities | 138.8 | 134.74 | 165.79 | 203.19 | 175.42 | 298.46 |
Long-Term Unearned Revenue | 32.06 | 34.64 | 38.24 | 41.8 | 47.76 | 47.7 |
Long-Term Deferred Tax Liabilities | 1.46 | 1.06 | 0.19 | 0.19 | 0.2 | 0.21 |
Total Liabilities | 190.05 | 170.43 | 204.22 | 245.18 | 223.39 | 346.37 |
Common Stock | 156 | 120 | 90 | 90 | 90 | 90 |
Additional Paid-In Capital | 678.95 | 710.69 | 350.13 | 347.62 | 338.7 | 330.18 |
Retained Earnings | 623.73 | 589.44 | 469.22 | 345.68 | 188.34 | 56.71 |
Comprehensive Income & Other | -0.38 | -0 | - | - | - | - |
Shareholders' Equity | 1,458 | 1,420 | 909.35 | 783.29 | 617.04 | 476.9 |
Total Liabilities & Equity | 1,648 | 1,591 | 1,114 | 1,028 | 840.43 | 823.27 |
Total Debt | 21.59 | - | - | 30.04 | 50.05 | 69.55 |
Net Cash (Debt) | 714.64 | 721.81 | 226.24 | 148.21 | 47.75 | 25.13 |
Net Cash Growth | 131.10% | 219.05% | 52.65% | 210.40% | 89.99% | - |
Net Cash Per Share | 4.69 | 5.87 | 1.93 | 1.27 | 0.41 | 0.24 |
Filing Date Shares Outstanding | 156 | 156 | 117 | 117 | 117 | 104.07 |
Total Common Shares Outstanding | 156 | 156 | 117 | 117 | 117 | 104.07 |
Working Capital | 1,014 | 1,000 | 474.99 | 368.82 | 235.18 | 113.51 |
Book Value Per Share | 9.35 | 9.10 | 7.77 | 6.70 | 5.27 | 4.58 |
Tangible Book Value | 1,401 | 1,362 | 849.43 | 721.91 | 553.85 | 411.87 |
Tangible Book Value Per Share | 8.98 | 8.73 | 7.26 | 6.17 | 4.73 | 3.96 |
Buildings | - | 295.48 | 294.63 | 241.34 | 233.68 | 184.41 |
Machinery | - | 346.13 | 321.4 | 303.54 | 259.27 | 240.75 |
Construction In Progress | - | 4.97 | 11.9 | 17.36 | 7.33 | 24.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.